Role of Ultrasound in Early Detection of Molar Pregnancy
DOI:
https://doi.org/10.37762/jgmds.9-4.339Keywords:
Fetal Poles, Gestational Trophoblastic Disease (GTD), Snow Storm AppearanceAbstract
OBJECTIVES
The objective of this study was to investigate the role of ultrasound in the detection of early pregnancies presenting with placental molar changes.
METHODOLOGY
This retrospective study was carried out at Radiology department of Hayatabad Medical Complex, Peshawar, between Aug 2020 and July 2021. All cases suspected of molar changes were evaluated from 10-14 weeks of gestation. The patient were referred to our department because of fetal abnormality, maternal disease or age and family or previous pregnancy history or were identified from an ongoing ultrasound screening study for aneuploidy by measurement of fetal nuchal translucency thickness. Transabdominal or transvaginal sonography was used to examine the fetus and placenta.
RESULTS
Total 85 patients of molar pregnancies were enrolled in the study. Age ranged between 20-45 years with a mean age of 32.5 years. There were 60(70.6%) complete moles (CM) and 25(27.4%) partial moles (PM) were suspected on ultrasound. In case of complete mole coexisting with a normal singleton or twin pregnancy, the molar placenta was clearly separated from the normal placenta, whereas with partial moles the molar structures were dispersed inside the placental mass.
CONCLUSION
Ultrasound detection of molar pregnancy remains a diagnostic challenge. Data suggest that there has been an increase in both the predictive value and the sensitivity of ultrasound over time; however, the diagnostic criteria remain ill defined. Prior to managing a miscarriage, being aware of the possibility of molar pregnancy will guide treatment and allow for adequate follow-up.
Downloads
Metrics
References
Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet. 2018 Oct. 143 Suppl 2:79-85
Eagles N, Sebire NJ, Short D, et al. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles. Hum Reprod 2016; 31: 1379
Ngan HY, Seckl MJ, Berkowitz RS, et al. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet 2015; 131 Suppl 2: S123–S126
Fisher RA, Maher GJ. Genetics of gestational trophoblastic disease. Best Practice & Research Clinical Obstetrics & Gynaecology. 2021 Jul 1;74:29-41
Lama P, Pariyar J. Histological analysis of the products of conception in first trimester spontaneous abortions. Nepal Journal of Obstetrics and Gynaecology. 2021 Jun 7;16(1)
Braga A, Biscaro A, do Amaral Giordani JM, Viggiano M, Elias KM, Berkowitz RS, Seckl MJ. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2018 Apr 1;223:50-5
Coyle C, Short D, Jackson L, Sebire NJ, Kaur B, Harvey R, et al. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients. Gynecol Oncol. 2018 Feb. 148 (2):254-257.
Horowitz NS, Berkowitz RS, Elias KM. Considering changes in the recommended human chorionic gonadotropin monitoring after molar evacuation. Obstet Gynecol. 2020 Jan. 135 (1):9-11
Wang Q, Fu J, Hu L, Fang F, Xie L, Chen H, et al. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2017, 11(9): 72-89
Zhao P, Chen Q, Lu W. Comparison of different therapeutic strategies for complete hydatidiform mole in women at least 40 years old: a retrospective cohort study. BMC Cancer. 2017 Nov 9. 17 (1):733
Ito Y, Maehara K, Kaneki E, et al. Novel nonsense mutation in the NLRP7 gene associated with recurrent hydatidiform mole. Gynecol Obstet Invest. 2015.11(2):111-14
Fatemi N, Ray PF, Ramezanali F, Shahani T, Amiri-Yekta A, Kherraf ZE, Cazin C, Almadani N, Varkiani M, Sarmadi S, Sodeifi N. KH domain containing 3 like (KHDC3L) frame-shift mutation causes both recurrent pregnancy loss and hydatidiform mole. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2021 Apr 1;259:100-4
Melamed A, Gockley AA, Joseph NT, Sun SY, Clapp MA, Goldstein DP, et al. Effect of race/ethnicity on risk of complete and partial molar pregnancy after adjustment for age. Gynecol Oncol. 2016 Oct. 143 (1):73-76
Sun SY, Melamed A, Goldstein DP, et al. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?. Gynecol Oncol. 2015, 138 (1):46-9
Wang X, Xie J, Wu Y, Wu X, Yan S, Xu Y, Zhu P, Hao J, Tao F, Huang K. Gender-specific effect of pregnancy-related anxiety on preschooler's emotional and behavioral development: a population-based cohort study. Journal of Affective Disorders. 2021 Jan 15;279:368-76
Karim N, Maqsood F, Khan K. Pre and Post-Operative Dental Pain and Anxiety in Patients Undergoing Routine Dental Extraction, Peshawar. Journal of Gandhara Medical and Dental Science. 2020 Jul 22;7(1):22-9
Savage JL, Maturen KE, Mowers EL, et al. Sonographic diagnosis of partial versus complete molar pregnancy: a reappraisal. J Clin Ultrasound 2017; 45: 72–78
Gadducci A, Cosio S, Fanucchi A, et al. Prognosis of Patients with Gestational Trophoblastic Neoplasia and Obstetric Outcomes of Those Conceiving After Chemotherapy. Anticancer Res. 2016 Jul. 36 (7):3477-82
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Adnan Ahmad, Mehreen Samad, Sadia Ahmad, Naila Tamkeen, Ghazala Wahid, Naveed Ahmad
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
